Menzella F - Search Results

1

Severe refractory asthma: current treatment options and ongoing research.

Menzella F, Bertolini F, Biava M, Galeone C, Scelfo C, Caminati M. Menzella F, et al. Drugs Context. 2018 Dec 5;7:212561. doi: 10.7573/dic.212561. eCollection 2018. Drugs Context. 2018. PMID: 30534175 Free PMC article. Review.

2

Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study.

Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI; GLIMP investigators. Aliberti S, et al. Lancet Infect Dis. 2016 Dec;16(12):1364-1376. doi: 10.1016/S1473-3099(16)30267-5. Epub 2016 Sep 1. Lancet Infect Dis. 2016. PMID: 27593581 Free article.

3

A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practice.

Menzella F, Zucchi L, Piro R, Galeone C, Castagnetti C, Facciolongo N. Menzella F, et al. Adv Ther. 2014 Jul;31(7):751-61. doi: 10.1007/s12325-014-0135-7. Epub 2014 Jul 10. Adv Ther. 2014. PMID: 25009004

4

Tailored therapy for severe asthma.

Menzella F, Lusuardi M, Galeone C, Zucchi L. Menzella F, et al. Multidiscip Respir Med. 2015 Jan 16;10(1):1. doi: 10.1186/2049-6958-10-1. eCollection 2015. Multidiscip Respir Med. 2015. PMID: 25671117 Free PMC article. Review.

5

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report.

Facciolongo N, Menzella F, Lusuardi M, Piro R, Galeone C, Castagnetti C, Cavazza A, Carbonelli C, Zucchi L, Salsi PP. Facciolongo N, et al. Among authors: menzella f. Multidiscip Respir Med. 2015 Mar 8;10(1):9. doi: 10.1186/s40248-015-0002-7. eCollection 2015. Multidiscip Respir Med. 2015. PMID: 25852934 Free PMC article.

6

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases.

Menzella F, Lusuardi M, Galeone C, Taddei S, Zucchi L. Menzella F, et al. J Asthma Allergy. 2015 Oct 8;8:105-14. doi: 10.2147/JAA.S40244. eCollection 2015. J Asthma Allergy. 2015. PMID: 26504401 Free PMC article. Review.

7

Clinical usefulness of mepolizumab in severe eosinophilic asthma.

Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L. Menzella F, et al. Ther Clin Risk Manag. 2016 Jun 8;12:907-16. doi: 10.2147/TCRM.S86299. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27354806 Free PMC article. Review.

8

The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Menzella F, Lusuardi M, Galeone C, Facciolongo N, Zucchi L. Menzella F, et al. Ther Adv Respir Dis. 2016 Dec;10(6):534-548. doi: 10.1177/1753465816667659. Epub 2016 Sep 9. Ther Adv Respir Dis. 2016. PMID: 27612492 Free PMC article. Review.

9

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Menzella F, Lusuardi M, Galeone C, Taddei S, Facciolongo N, Zucchi L. Menzella F, et al. Ther Adv Chronic Dis. 2016 Nov;7(6):260-277. doi: 10.1177/2040622316659863. Epub 2016 Aug 11. Ther Adv Chronic Dis. 2016. PMID: 27803792 Free PMC article. Review.

10

Real-life Efficacy of Omalizumab After 9 Years of Follow-up.

Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, Zucchi L. Menzella F, et al. Allergy Asthma Immunol Res. 2017 Jul;9(4):368-372. doi: 10.4168/aair.2017.9.4.368. Allergy Asthma Immunol Res. 2017. PMID: 28497924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page